These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9329440)

  • 21. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.
    Ammann AJ; Addiego J; Wara DW; Lubin B; Smith WB; Mentzer WC
    N Engl J Med; 1977 Oct; 297(17):897-900. PubMed ID: 20575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revaccination of high-risk adults with pneumococcal polysaccharide vaccine.
    Nichol KL
    JAMA; 1999 Jan; 281(3):280-1. PubMed ID: 9918486
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody responses to pneumococcal capsular polysaccharide: what is being measured?
    Goldblatt D; Jadresic LP; Levinsky RJ; Turner MW
    Immunodeficiency; 1993; 4(1-4):47-50. PubMed ID: 8167732
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomized individuals with varying vaccination status.
    Konradsen HB; Rasmussen C; Ejstrud P; Hansen JB
    Epidemiol Infect; 1997 Oct; 119(2):167-74. PubMed ID: 9363015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Severe pneumococcal infections and immunologic deficiency in children].
    Reinert P; Bernaudin F; Lassale C; Lemerle S
    Bull Eur Physiopathol Respir; 1983; 19(2):205-8. PubMed ID: 6871499
    [No Abstract]   [Full Text] [Related]  

  • 26. Pneumococcal vaccines.
    Hilleman MR; McLean AA; Vella PP; Weibel RE; Woodhour AF
    Pathol Biol (Paris); 1979 Nov; 27(9):579-88. PubMed ID: 44742
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute pulmonary disease and sickle cell anemia.
    Barrett-Connor E
    Am Rev Respir Dis; 1971 Aug; 104(2):159-65. PubMed ID: 4397701
    [No Abstract]   [Full Text] [Related]  

  • 28. Current status of pneumococcal polysaccharide immunization in patients with sickle cell disease or impaired splenic function.
    Ammann AJ
    Am J Pediatr Hematol Oncol; 1982; 4(3):301-6. PubMed ID: 7149168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-pneumococcal antibody levels three to seven years after first booster immunization in children with sickle cell disease, and after a second booster.
    Rao SP; Rajkumar K; Schiffman G; Desai N; Unger C; Miller ST
    J Pediatr; 1995 Oct; 127(4):590-2. PubMed ID: 7562281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.
    O'Brien KL; Swift AJ; Winkelstein JA; Santosham M; Stover B; Luddy R; Gootenberg JE; Nold JT; Eskenazi A; Snader SJ; Lederman HM
    Pediatrics; 2000 Nov; 106(5):965-72. PubMed ID: 11061761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumococcal polysaccharide vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Feb; 38(5):64-8, 73-6. PubMed ID: 2492366
    [No Abstract]   [Full Text] [Related]  

  • 32. Pneumonia and bacteremia by pneumococcal serotype 16 in a human immunodeficiency virus-infected child with normal serum antibody response to 23-valent pneumovax vaccine.
    Hirschfeld S; Schiffman G; Tudor-Williams G; Pizzo PA
    J Infect Dis; 1995 Mar; 171(3):761-2. PubMed ID: 7876638
    [No Abstract]   [Full Text] [Related]  

  • 33. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response.
    Rodriguez-Barradas MC; Groover JE; Lacke CE; Gump DW; Lahart CJ; Pandey JP; Musher DM
    J Infect Dis; 1996 Jun; 173(6):1347-53. PubMed ID: 8648206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiologic and serologic studies of pneumococcal infections with reference to the new STIKO recommendations].
    Hülsse C; Littmann M; Fiedler K; Kaltofen U; Hundt C
    Gesundheitswesen; 1999; 61(8-9):393-7. PubMed ID: 10535219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leads from the MMWR. Recommendations of the Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine.
    JAMA; 1989 Mar; 261(9):1265-7. PubMed ID: 2644464
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the clinical application of pneumococcal vaccine. Distribution of Streptococcus pneumoniae in Japan].
    Fukumi H; Kaneko Y; Agata T; Takayanagi M; Yoshioka H; Fujita K; Kawana R; Shimada K; Inamatsu T; Urayama K
    Kansenshogaku Zasshi; 1984 Jan; 58(1):39-53. PubMed ID: 6434647
    [No Abstract]   [Full Text] [Related]  

  • 37. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II.
    Falletta JM; Woods GM; Verter JI; Buchanan GR; Pegelow CH; Iyer RV; Miller ST; Holbrook CT; Kinney TR; Vichinsky E
    J Pediatr; 1995 Nov; 127(5):685-90. PubMed ID: 7472817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
    Hidalgo H; Moore C; Leiva LE; Sorensen RU
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of sickle cell disease in primary care.
    Wilson RE; Krishnamurti L; Kamat D
    Clin Pediatr (Phila); 2003; 42(9):753-61. PubMed ID: 14686547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.